Recent research indicates a potential link between GLP-1 receptor agonist medications—like semaglutide, found in Ozempic and Wegovy—and decreased violent tendencies. Initially investigated for weight loss and other health benefits, these drugs are now being studied for their possible impact on behavioral patterns. A new study published Wednesday suggests GLP-1 medications may actively reduce violent impulses. Researchers have observed this connection over several years, noting effects beyond weight management. While the mechanisms are still under investigation, the findings offer a novel perspective on treating aggression. Further research is needed to confirm these results and understand the full scope of the relationship between GLP-1 drugs and violent behavior.